JOP20190275B1 - طرق وتركيبات لعلاج اضطراب إسهال خِلقي - Google Patents
طرق وتركيبات لعلاج اضطراب إسهال خِلقيInfo
- Publication number
- JOP20190275B1 JOP20190275B1 JOJO/P/2019/0275A JOP20190275A JOP20190275B1 JO P20190275 B1 JOP20190275 B1 JO P20190275B1 JO P20190275 A JOP20190275 A JO P20190275A JO P20190275 B1 JOP20190275 B1 JO P20190275B1
- Authority
- JO
- Jordan
- Prior art keywords
- methods
- compositions
- disorder
- treating congenital
- cdd
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762513251P | 2017-05-31 | 2017-05-31 | |
| PCT/US2018/035468 WO2018222919A1 (en) | 2017-05-31 | 2018-05-31 | Methods and compositions for treating congenital diarrhea disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JOP20190275A1 JOP20190275A1 (ar) | 2019-11-27 |
| JOP20190275B1 true JOP20190275B1 (ar) | 2024-12-22 |
Family
ID=64455032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOJO/P/2019/0275A JOP20190275B1 (ar) | 2017-05-31 | 2018-05-31 | طرق وتركيبات لعلاج اضطراب إسهال خِلقي |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11857510B2 (https=) |
| EP (1) | EP3634581B8 (https=) |
| JP (1) | JP2020525407A (https=) |
| CN (1) | CN110831667A (https=) |
| AU (1) | AU2018278312B2 (https=) |
| CA (1) | CA3065797A1 (https=) |
| DK (1) | DK3634581T3 (https=) |
| ES (1) | ES2988850T3 (https=) |
| FI (1) | FI3634581T3 (https=) |
| IL (1) | IL270984B1 (https=) |
| JO (1) | JOP20190275B1 (https=) |
| WO (1) | WO2018222919A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7328153B2 (ja) | 2017-05-31 | 2023-08-16 | ナポ ファーマシューティカルズ インク． | 胆汁酸性下痢、小腸切除又は胆嚢除去及び短腸症候群に関連する下痢を治療するための方法及び組成物 |
| US11857510B2 (en) | 2017-05-31 | 2024-01-02 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating congenital diarrhea disorder |
| CA3182864A1 (en) * | 2020-06-19 | 2021-12-23 | Lisa A. CONTE | Methods and compositions for treating chemotherapy-induced diarrhea |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3564370D1 (en) | 1985-08-30 | 1988-09-22 | Nestle Sa | Dietetic product with depurating and antidiarrheal activity and process for its preparation |
| US5211944A (en) | 1990-10-12 | 1993-05-18 | Shaman Pharmaceuticals, Inc. | Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| SI9011933A (sl) | 1990-10-15 | 1998-06-30 | TANIN SEVNICA Kemična industrija p.o. | Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba |
| EP2060183A3 (en) | 1996-10-16 | 2009-06-03 | Napo Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| US7767203B2 (en) | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| WO2000047062A2 (en) | 1999-02-01 | 2000-08-17 | Shaman Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same |
| US7235573B2 (en) | 2002-09-30 | 2007-06-26 | The Regents Of The University Of California | Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors |
| US20070254050A1 (en) | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| SI2241318T1 (sl) | 2006-05-01 | 2013-04-30 | Napo Pharmaceuticals, Inc. | Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo |
| ES2616012T3 (es) | 2006-05-01 | 2017-06-09 | Napo Pharmaceuticals, Inc. | Composiciones para tratar o prevenir enfermedad inflamatoria del intestino |
| AU2010303577B2 (en) | 2009-10-06 | 2015-10-22 | Napo Pharmaceuticals, Inc. | Methods of treating diseases with proanthocyanidin oligomers such as crofelemer |
| CN107595836A (zh) | 2010-10-31 | 2018-01-19 | 纳珀制药公司 | 用于治疗hiv相关性腹泻的方法和组合物 |
| EP3393460A4 (en) * | 2015-12-23 | 2019-09-25 | Vanessa Research, Inc. | COMPOSITIONS AND METHODS FOR TREATING MVID AND RELATED DISEASES |
| US11389424B2 (en) | 2017-03-09 | 2022-07-19 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating chemotherapy-induced diarrhea |
| JP7328153B2 (ja) | 2017-05-31 | 2023-08-16 | ナポ ファーマシューティカルズ インク． | 胆汁酸性下痢、小腸切除又は胆嚢除去及び短腸症候群に関連する下痢を治療するための方法及び組成物 |
| US11857510B2 (en) | 2017-05-31 | 2024-01-02 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating congenital diarrhea disorder |
-
2018
- 2018-05-31 US US16/617,463 patent/US11857510B2/en active Active
- 2018-05-31 JP JP2019566125A patent/JP2020525407A/ja active Pending
- 2018-05-31 AU AU2018278312A patent/AU2018278312B2/en active Active
- 2018-05-31 EP EP18810153.9A patent/EP3634581B8/en active Active
- 2018-05-31 JO JOJO/P/2019/0275A patent/JOP20190275B1/ar active
- 2018-05-31 DK DK18810153.9T patent/DK3634581T3/da active
- 2018-05-31 ES ES18810153T patent/ES2988850T3/es active Active
- 2018-05-31 CA CA3065797A patent/CA3065797A1/en active Pending
- 2018-05-31 CN CN201880043974.4A patent/CN110831667A/zh active Pending
- 2018-05-31 FI FIEP18810153.9T patent/FI3634581T3/fi active
- 2018-05-31 WO PCT/US2018/035468 patent/WO2018222919A1/en not_active Ceased
-
2019
- 2019-11-27 IL IL270984A patent/IL270984B1/en unknown
-
2023
- 2023-11-27 US US18/520,464 patent/US20240325346A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3634581B1 (en) | 2024-07-31 |
| EP3634581A4 (en) | 2021-02-24 |
| DK3634581T3 (da) | 2024-08-26 |
| AU2018278312B2 (en) | 2024-07-04 |
| US20240325346A1 (en) | 2024-10-03 |
| JOP20190275A1 (ar) | 2019-11-27 |
| EP3634581B8 (en) | 2024-09-11 |
| CN110831667A (zh) | 2020-02-21 |
| ES2988850T3 (es) | 2024-11-21 |
| JP2020525407A (ja) | 2020-08-27 |
| AU2018278312A1 (en) | 2020-01-02 |
| WO2018222919A1 (en) | 2018-12-06 |
| IL270984A (en) | 2020-01-30 |
| FI3634581T3 (fi) | 2024-08-16 |
| US11857510B2 (en) | 2024-01-02 |
| IL270984B1 (en) | 2026-01-01 |
| CA3065797A1 (en) | 2018-12-06 |
| US20200108047A1 (en) | 2020-04-09 |
| EP3634581A1 (en) | 2020-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA518392101B1 (ar) | ROR-Gamma مشتقات البنزيميدازول في صورة مُعدلات لـ | |
| CR20210500A (es) | Anticuerpos de cadena pesada que se unen al psma | |
| PH12020550051A1 (en) | Glp-1 compositions and uses thereof | |
| MX2021005365A (es) | Preparaciones y composiciones de oligosacaridos. | |
| MX2018006223A (es) | Moduladores de ror-gamma. | |
| MX386086B (es) | Composicion de cannabis | |
| BR112018010024A8 (pt) | compostos e composições úteis no tratamento de distúrbios relacionados a ntrk | |
| MX2017009720A (es) | Composiciones de oligosacaridos para el uso en composiciones nutricionales y metodos para producirlas. | |
| MX2013004061A (es) | Analogos de ciclosporina. | |
| MX380669B (es) | Heteroarilhidroxipirimidinonas como agonistas del receptor de apelina (apj). | |
| MX2024001617A (es) | Composiciones biofarmaceuticas. | |
| BR112019017393A2 (pt) | formulações de evolocumab de baixa viscosidade, alta concentração e métodos para produzir as mesmas | |
| CR20220656A (es) | Unión de anticuerpos multiespecíficos a bcma | |
| EA202190927A1 (ru) | Иммуноаблативные виды терапии | |
| JOP20190275B1 (ar) | طرق وتركيبات لعلاج اضطراب إسهال خِلقي | |
| MX2016000423A (es) | Metodos para promover el desarrollo neuronal y/o la salud que comprende la administracion de una combinacion de acido docosahexaenoico y acido alfa-lipoico. | |
| MY209035A (en) | Tricyclic compounds and their use | |
| PH12021551075A1 (en) | A NUTRITIONAL COMPOSITION COMPRISING METABOLITES OF HMOs TO IMPROVE THE GASTROINTESTINAL BARRIER | |
| MX2023008191A (es) | Productos bioterapéuticos hipoinmunogénicos. | |
| EA202090732A1 (ru) | Составы для трансдермального введения | |
| PH12015502100A1 (en) | Reducing the risk of autoimmune disease | |
| BR112017024065A2 (pt) | método para tratar insuficiência cardíaca avançada em um indivíduo humano | |
| EA201891752A2 (ru) | Фармацевтическая композиция для улучшения состояния при хронической почечной недостаточности или предотвращения ее прогрессирования | |
| ZA202002740B (en) | Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5h-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione | |
| WO2020210570A3 (en) | Gm3 synthase vectors and uses thereof |